Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Clinical trial NCT03937791 · TERMINATED

Trial details

NCT number: NCT03937791
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Lntraepithelial Lesions of Vulva Neoplasms, Squamous Cell Vulvar HSIL

Start date: 2019-10-09
Primary completion: 2020-06-22
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.